Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Privia Health (PRVA) Common Equity (2020 - 2026)

Privia Health has reported Common Equity over the past 6 years, most recently at $790.9 million for Q4 2025.

  • For Q4 2025, Common Equity rose 15.73% year-over-year to $790.9 million; the TTM value through Dec 2025 reached $790.9 million, up 15.73%, while the annual FY2025 figure was $790.9 million, 15.73% up from the prior year.
  • Common Equity for Q4 2025 was $790.9 million at Privia Health, up from $762.8 million in the prior quarter.
  • Over five years, Common Equity peaked at $790.9 million in Q4 2025 and troughed at $149.4 million in Q1 2021.
  • A 5-year average of $563.2 million and a median of $581.2 million in 2023 define the central range for Common Equity.
  • Biggest five-year swings in Common Equity: soared 229.44% in 2021 and later rose 11.91% in 2024.
  • Year by year, Common Equity stood at $450.2 million in 2021, then increased by 15.3% to $519.0 million in 2022, then rose by 17.02% to $607.4 million in 2023, then increased by 12.52% to $683.4 million in 2024, then increased by 15.73% to $790.9 million in 2025.
  • Business Quant data shows Common Equity for PRVA at $790.9 million in Q4 2025, $762.8 million in Q3 2025, and $733.5 million in Q2 2025.